<i>KMT2D</i> mutations and <i>TP53</i> disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL studySimone Ferrero, Gianluca Gaïdano, Davide Rossi et al.|Haematologica|2019Cited by 137
Targeting p53 in chronic lymphocytic leukemiaRiccardo Moia, Gianluca Gaïdano, Paola Boggione et al.|Expert Opinion on Therapeutic Targets|2020Cited by 26
Clonally unrelated Richter syndrome are truly de novo diffuse large B‐cell lymphomas with a mutational profile reminiscent of clonally related Richter syndromeChiara Favini, Riccardo Moia, Nariman Alessa et al.|British Journal of Haematology|2022Cited by 24
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleationGerard Llimos, Bart Deplancke, Vincent Gardeux et al.|Nature Communications|2022Cited by 18
Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levelsRiccardo Moia, Robin Foà, Donatella Talotta et al.|Blood Advances|2025Cited by 17